Finceramica is a company which develops, manufactures and markets innovative therapeutic solutions for the biomedical sector. The work carried out at Finceramica lies at the junction between the thousand-year old evolution of ceramic processes and innovation in biomaterials, biosciences and "regenerative surgery". Our research activities revolve around the human being and the specific needs of patients and surgeons. Our technology platform is a concrete answer to the daily requirements faced by orthopaedic surgery, neurosurgery and maxillofacial surgery.
The innovative technologies developed by Finceramica in collaboration with internationally renowned research institutes have paved the way to new generations of biomaterials able to interact with and integrate in the human body, and eventually regenerate damaged bone tissues. One of the materials Finceramica is investigating most closely is hydroxyapatite, the bioceramic material which makes up 70% of the human bone. Once implanted, new generation hydroxyapatite-based biomaterials form an ideal micro-environment to biologically support the development of the new bone.
Our main goal is to develop, manufacture and market innovative therapeutic solutions which:
are safe and effective for the patient
meet the real needs of the surgeon
prove to be cost-effective for the health system as a whole
We are aware of the social responsibility that we have as an organisation and are guided by the following values:
a passion for science
care for the human being
confidence in teamwork
compliance with the rules and the highest quality standards
Finceramica was established in 1987 at the initiative of a researcher working for the then IRTEC-CNR (Institute for Science and Technology for Ceramics-National Research Council), who for long had been focusing on the biomedical field. All the stakeholders, who were private subjects, believed in his innovative ideas and decided to make them come to life. In 1992 the company started operating as a spin-off of the Institute for Science and Technology for Ceramics of the National Research Council, with the Tampieri brothers, Federico, Adriano and Giovanni, participating in its equity.
In 2005 the Tampieri Group took it over as the sole shareholder, as part of the recently approved business development plan and of a new phase of expansion fostered by new managers. While maintaining its focus on research, Finceramica started releasing its business potential, which resulted in rapid growth. The range of products widened and important agreements were signed with leading companies in the biomedical sector.
Finceramica's innovative projects are carried out by a young, dynamic and forward-looking team made up of highly qualified experts who communicate and operate daily within an international network. Their expertise ranges from materials science to engineering, from biology to medical sciences, from marketing to sales. We are strong believers in teamwork, especially in the biomedical field, where a multidisciplinary approach is crucial for success.
Our corporate structure reflects both our customer-oriented culture, informed by such criteria as agility, flexibility and efficiency, and our commitment to constantly developing new biotechnologies.
On December 31st 2023 34 people were employed.
The general terms and conditions of sale shall apply to all contracts between Finceramica and its customers, related to the supply of goods as of 1 may 2015.
Together with the purchase order or any other summary document, they represent the whole of the agreements regulating the contractual relationships.
Below are the documents for download:
Ethics matter to us. Our integrity resonates within every action we take and guides us to achieve our corporate objectives.
Therefore Finceramica has decided to adhere to the principles laid out in Legislative Decree 231/01 of the Italian Law, adopting an organizational model and availing themselves of a supervisory body.
The organizational model is based on the code of ethics, which is the main tool for implementing ethics within the company.
This represents a behavioural model whose principles underlie every activity carried out within or without the Group companies.
code of ethics (download pdf)
Finceramica’s quality system is organized according to the requirements
. ISO 9001
. ISO 13485
The priority of Finceramica is the achievement of a high level of quality applied to the products and services provided.
The company also implements a quality policy aimed at continuous improvement to maintain a leadership position on the market and to ensure its customers safe and innovative products and services. Below, you will find the management declaration and quality policy, signed by the CEO (download pdf)
We care about our staff. They belong to the extended Finceramica Tampieri family.
Great news!
From today you can upload your CV directly here
With this new procedure it will be easier for us to contact you directly if your profile matches our needs.
For a while, we need you to send your cv also to the email address recruitment@finceramica.it : thanks for your cooperation.
